Trinity Biotech Plc logo

Trinity Biotech Plc share price today

(TRIB)

Trinity Biotech Plc share price is $1.02 & ₹87.53 as on 7 Jan 2025, 2.30 'hrs' IST

$1.02

0.08

(9.04%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Trinity Biotech Plc share price in Dollar and Rupees. Guide to invest in Trinity Biotech Plc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Trinity Biotech Plc, along with analyst recommendations, forecasts, and comprehensive financials.

Trinity Biotech Plc share price movements

  • Today's Low: $0.91
    Today's High: $1.02

    Day's Volatility :11.21%

  • 52 Weeks Low: $0.75
    52 Weeks High: $3.55

    52 Weeks Volatility :78.87%

Trinity Biotech Plc Returns

PeriodTrinity Biotech PlcIndex (Russel 2000)
3 Months
-39.85%
0.0%
6 Months
-61.51%
0.0%
1 Year
-60.35%
0.0%
3 Years
-85.72%
-19.8%

Trinity Biotech Plc Key Statistics

in dollars & INR

Previous Close
$0.9354
Open
$0.94
Today's High
$1.0249
Today's Low
$0.91
Market Capitalization
$24.2M
Today's Volume
$232.0K
52 Week High
$3.55
52 Week Low
$0.75
Revenue TTM
$58.7M
EBITDA
$-11.3M
Earnings Per Share (EPS)
$-2.25
Profit Margin
-38.01%
Quarterly Earnings Growth YOY
-0.77%
Return On Equity TTM
-1913.45%

How to invest in Trinity Biotech Plc from India?

It is very easy for Indian residents to invest directly in Trinity Biotech Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Trinity Biotech Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Trinity Biotech Plc or TRIB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Trinity Biotech Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Trinity Biotech Plc shares which would translate to 0.841 fractional shares of Trinity Biotech Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Trinity Biotech Plc, in just a few clicks!

Returns in Trinity Biotech Plc for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Trinity Biotech Plc investment value today

Current value as on today

₹46,443

Returns

₹53,557

(-53.56%)

Returns from Trinity Biotech Plc Stock

₹56,780 (-56.78%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Trinity Biotech Plc

45%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Trinity Biotech Plc on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 45% more investors are searching Trinity Biotech Plc in the last 30 days versus the previous period.

Global Institutional Holdings in Trinity Biotech Plc

  • Perceptive Advisors LLC

    6.54%

  • Hunter Associates Inc.

    1.31%

  • Renaissance Technologies Corp

    0.91%

  • Whitefort Capital Management, LP.

    0.30%

  • HRT FINANCIAL LLC

    0.12%

  • Moss Adams Wealth Advisors LLC

    0.09%

Analyst Recommendation on Trinity Biotech Plc

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Trinity Biotech Plc(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Trinity Biotech Plc

What analysts predicted

Upside of 194.12%

Current:

$1.02

Target:

$3.00

Insights on Trinity Biotech Plc

  • Price Movement

    In the last 6 months, TRIB stock has moved down by -54.1%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 15.84M → 15.15M (in $), with an average decrease of 4.4% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -6.75M → -4.75M (in $), with an average increase of 42.0% per quarter
  • TRIB vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 55.9% return, outperforming this stock by 120.6%
  • TRIB vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 112.9% return, outperforming this stock by 199.3%
  • Price to Sales

    ForTRIB every $1 of sales, investors are willing to pay $0.1, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Trinity Biotech Plc Financials in INR & Dollars

FY18Y/Y Change
Revenue
$97.0M
↓ 2.12%
Net Income
$2.4M
↓ 105.93%
Net Profit Margin
2.46%
↑ 43.08%
FY19Y/Y Change
Revenue
$90.4M
↓ 6.8%
Net Income
$-4.1M
↓ 270.13%
Net Profit Margin
-4.5%
↓ 6.96%
FY20Y/Y Change
Revenue
$102.0M
↑ 12.77%
Net Income
$-6.0M
↑ 47.88%
Net Profit Margin
-5.9%
↓ 1.4%
FY21Y/Y Change
Revenue
$93.0M
↓ 8.84%
Net Income
$875.0K
↓ 114.55%
Net Profit Margin
0.94%
↑ 6.84%
FY22Y/Y Change
Revenue
$74.8M
↓ 19.56%
Net Income
$-41.0M
↓ 4785.94%
Net Profit Margin
-54.83%
↓ 55.77%
FY23Y/Y Change
Revenue
$56.8M
↓ 24.0%
Net Income
$-24.0M
↓ 41.42%
Net Profit Margin
-42.26%
↑ 12.57%
Q2 FY23Q/Q Change
Revenue
$14.7M
↓ 18.62%
Net Income
$-6.7M
↓ 33.3%
Net Profit Margin
-45.79%
↑ 10.08%
Q3 FY23Q/Q Change
Revenue
$14.7M
↑ 0.0%
Net Income
$-6.7M
↑ 0.0%
Net Profit Margin
-45.79%
↑ 0.0%
Q4 FY23Q/Q Change
Revenue
$14.7M
↑ 0.18%
Net Income
$-3.3M
↓ 50.65%
Net Profit Margin
-22.56%
↑ 23.23%
Q1 FY24Q/Q Change
Revenue
$13.4M
↓ 8.68%
Net Income
$-5.5M
↑ 65.87%
Net Profit Margin
-40.97%
↓ 18.41%
Q2 FY24Q/Q Change
Revenue
$15.8M
↑ 17.98%
Net Income
$-6.8M
↑ 22.81%
Net Profit Margin
-42.65%
↓ 1.68%
Q3 FY24Q/Q Change
Revenue
$15.2M
↓ 4.36%
Net Income
$-4.8M
↓ 29.57%
Net Profit Margin
-31.41%
↑ 11.24%
FY18Y/Y Change
Profit
$41.4M
↓ 1.05%
FY19Y/Y Change
Profit
$38.1M
↓ 8.03%
FY20Y/Y Change
Profit
$48.6M
↑ 27.44%
FY21Y/Y Change
Profit
$38.1M
↓ 21.62%
FY22Y/Y Change
Profit
$22.0M
↓ 42.1%
FY23Y/Y Change
Profit
$19.5M
↓ 11.78%
Q2 FY23Q/Q Change
Profit
$4.3M
↓ 31.37%
Q3 FY23Q/Q Change
Profit
$4.3M
↑ 0.0%
Q4 FY23Q/Q Change
Profit
$5.0M
↑ 16.71%
Q1 FY24Q/Q Change
Profit
$4.1M
↓ 17.78%
Q2 FY24Q/Q Change
Profit
$5.7M
↑ 39.62%
Q3 FY24Q/Q Change
Profit
$5.3M
↓ 7.43%
FY18Y/Y Change
Operating Cash Flow
$6.9M
↓ 42.74%
Investing Cash Flow
$-17.4M
↑ 7.48%
Financing Cash Flow
$-17.0M
↑ 11.37%
FY19Y/Y Change
Operating Cash Flow
$5.5M
↓ 21.07%
Investing Cash Flow
$-11.9M
↓ 31.84%
Financing Cash Flow
$-4.0M
↓ 76.47%
FY20Y/Y Change
Operating Cash Flow
$23.8M
↑ 333.96%
Investing Cash Flow
$-10.2M
↓ 13.96%
Financing Cash Flow
$-2.7M
↓ 32.03%
FY21Y/Y Change
Operating Cash Flow
$13.2M
↓ 44.27%
Investing Cash Flow
$-7.1M
↓ 30.68%
Financing Cash Flow
$-6.0M
↑ 121.61%
Q2 FY23Q/Q Change
Operating Cash Flow
$-4.7M
↓ 305.01%
Investing Cash Flow
$27.9M
↓ 2196.46%
Financing Cash Flow
$-2.4M
↑ 31.76%

Trinity Biotech Plc Technicals Summary

Sell

Neutral

Buy

Trinity Biotech Plc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Trinity Biotech Plc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Trinity Biotech Plc
6.3%
-61.51%
-60.35%
-85.72%
-82.18%
Stryker Corporation
-5.14%
7.73%
20.51%
37.02%
70.83%
Boston Scientific Corp.
2.22%
18.53%
55.24%
113.84%
98.4%
Edwards Lifesciences Corp.
4.25%
-20.93%
-2.33%
-38.47%
-5.21%
Abbott Laboratories
-0.93%
11.99%
1.27%
-15.84%
31.69%
Medtronic Plc
-3.59%
5.29%
-6.49%
-23.36%
-31.62%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Trinity Biotech Plc
0.56
NA
1.3
-1.74
-19.13
-0.1
NA
-3.12
Stryker Corporation
38.59
38.59
2.51
12.06
0.19
0.07
0.01
52.86
Boston Scientific Corp.
73.82
73.82
1.62
2.46
0.09
0.05
NA
14.05
Edwards Lifesciences Corp.
28.0
28.0
6.67
2.54
0.19
0.11
NA
16.18
Abbott Laboratories
34.38
34.38
2.19
4.68
0.15
0.06
0.02
22.94
Medtronic Plc
24.43
24.43
1.46
5.45
0.08
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Trinity Biotech Plc
Buy
$24.2M
-82.18%
0.56
-38.01%
Stryker Corporation
Buy
$137.3B
70.83%
38.59
16.34%
Boston Scientific Corp.
Buy
$131.6B
98.4%
73.82
11.26%
Edwards Lifesciences Corp.
Buy
$43.6B
-5.21%
28.0
65.86%
Abbott Laboratories
Buy
$196.2B
31.69%
34.38
13.99%
Medtronic Plc
Buy
$102.4B
-31.62%
24.43
12.06%

About Trinity Biotech Plc

since its formation in 1992, trinity biotech has actively pursued the aim of becoming a leading player in the international diagnostics industry. through a combination of sustained, organic growth and an acquisition-led strategy, the company has assembled an impressive product portfolio and achieved the highest standards of excellence in developing, manufacturing and marketing diagnostic products. the test kits manufactured by trinity biotech are used in the clinical laboratory and point-of-care segments of the diagnostic market to detect infectious diseases, sexually transmitted diseases, autoimmune and haemoglobin disorders, and detect, monitor and control diabetes. the company is also a significant provider of raw materials to the life sciences industry. trinity biotech, which has its headquarters in ireland, employs in excess of 350 people and markets its portfolio of over 400 products to customers in 80 countries around the world. it reaches this worldwide market by combining the
Organization
Trinity Biotech Plc
Employees
380
CEO
Mr. John Gillard
Industry
Health Technology

Management People of Trinity Biotech Plc

NameTitle
Mr. John Gillard
President, CEO, Company Secretary & Director
Mr. Ronan O'Caoimh A.C.A.
Founder, Director & Executive Advisor
Dr. James Walsh Ph.D.
Executive Director of Business Development & Executive Director
Ms. Louise Tallon
CFO & Chief Accounting Officer
Ms. Jacqueline O'Neill
Director of Operations
Dr. Gary Keating Ph.D.
Chief Technology Officer
Ms. Eibhlin Kelly
Chief Information Officer
Mr. Colm Molloy
Group Director of Human Resources & Culture
Mr. Adrian Donohue
Chief Commercial Officer

Important FAQs about investing in Trinity Biotech Plc from India :

What is Trinity Biotech Plc share price today?

Trinity Biotech Plc share price today stands at $1.02, Open: $0.94 ; Previous Close: $0.94 ; High: $1.02 ; Low: $0.91 ; 52 Week High: $3.55 ; 52 Week Low: $0.75. The stock opens at $0.94, after a previous close of $0.94. The stock reached a daily high of $1.02 and a low of $0.91, with a 52-week high of $3.55 and a 52-week low of $0.75.

Can Indians buy Trinity Biotech Plc shares?

Yes, Indians can invest in the Trinity Biotech Plc (TRIB) from India.

With INDmoney, you can buy Trinity Biotech Plc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Trinity Biotech Plc at zero transaction cost.

How can I buy Trinity Biotech Plc shares from India?

It is very easy to buy Trinity Biotech Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Trinity Biotech Plc be purchased?

Yes, you can buy fractional shares of Trinity Biotech Plc with INDmoney app.

What are the documents required to start investing in Trinity Biotech Plc stocks?

To start investing in Trinity Biotech Plc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Trinity Biotech Plc

Today’s highest price of Trinity Biotech Plc (TRIB) is $1.02.

Today’s lowest price of Trinity Biotech Plc (TRIB) is $0.91.

What is today's market capitalisation of Trinity Biotech Plc

Today's market capitalisation of Trinity Biotech Plc TRIB is 24.2M

What is the 52 Week High and Low Range of Trinity Biotech Plc

  • 52 Week High

    $3.55

  • 52 Week Low

    $0.75

What are the historical returns of Trinity Biotech Plc?

  • 1 Month Returns

    6.3%

  • 3 Months Returns

    -61.51%

  • 1 Year Returns

    -60.35%

  • 5 Years Returns

    -82.18%

Who is the Chief Executive Officer (CEO) of Trinity Biotech Plc

Mr. John Gillard is the current Chief Executive Officer (CEO) of Trinity Biotech Plc.